Abstract Body

Brain white matter hyperintensities (WMH) are nonspecific in etiology but occur commonly in the setting of HIV infection. Their relevance to disease remains uncertain as previous studies have used various methods of estimation in heterogenous groups of people with HIV (PWH). We evaluated the frequency, severity and clinical correlations of WMH in the setting of well controlled HIV infection, using the Fazekas visual rating scale.

Research protocol images from brain 3D fluid attenuated inversion recovery (FLAIR) on a 3T MRI were reviewed to determine the Fazekas score (total score of 0-6, 0-3 for periventricular hyperintensity and 0-3 for deep WMH) in people with HIV (PWH) with well controlled infection (antiretroviral therapy for at least one year and plasma viral load <200 copies/ml) and in controls. Simple linear regression was used for covariate selection, and forward stepwise regression was performed to evaluate the effect of HIV on Fazekas scores.

Fazekas scores were determined in 203 PWH and 58 controls. The PWH group had a higher mean total Fazekas score compared to controls (2.2±1 vs. 1.8±1.3, p=0.008). Age, history of cocaine abuse, prior smoking history, acetylsalicylic acid use, hepatitis C virus antibodies, higher hemoglobin A1C level (A1C), and lower estimated glomerular filtration rate were all associated with a higher Fazekas score in PWH and/or control group. The final forward stepwise regression model included age and history of cocaine abuse (n=200, R2=0.24), or age and A1C (n=242, R2=0.27). In both models, the adjusted mean total Fazekas score remained higher in the PWH group compared to the control group [2.3 (95%CI 2.1-2.5) vs. 2.0 (95%CI 1.7-2.3) with p=0.046 adjusted for age and cocaine abuse, 2.2 (95%CI 2.0-2.3) vs. 1.8 (95%CI 1.5-2.0) with p=0.0039 adjusted for age and A1C]. No specific cognitive measure correlated with the Fazekas score. In the PWH group, CD4 nadir <200 cells/ml was associated with a higher Fazekas score [age-adjusted mean 2.4 (95%CI 2.2-2.6) vs. 2.0 (95%CI 1.9-2.2), p=0.01].

HIV infection contributes to the extent of brain WMH, even in the setting of well controlled infection. Prior immunosuppression evidenced by lower nadir CD4 partially explains this association. The cohort is undergoing serial MRI scans and neuropsychological testing to evaluate the long-term clinical effects of WMH.